Sandra Laternser

Sandra Laternser

Sandra Laternser
ZHAW Life Sciences und Facility Management
Einsiedlerstrasse 31
8820 Wädenswil

+41 (0) 58 934 55 36
sandra.laternser@zhaw.ch

Persönliches Profil

Tätigkeit an der ZHAW als

Wissenschaftliche Mitarbeiterin / Fachstelle Zellbiologie und Tissue Engineering

https://www.zhaw.ch/de/lsfm/institute-zentren/icbt/zellbiologie-und-tissue-engineering/

Arbeits- und Forschungsschwerpunkte, Spezialkenntnisse

Zellkulturtechnik,
3D Zellkulturtechnik,
Gerüstfreie und gerüstbasierende Gewebekulturtechnik,
Knochenmikrotumore,
Muskelmodelle,
3D Bioprinting Technologie,
Mikroskopie und Bildanalyse,
Cell-based Assays,
Tagungs- und Eventorganisation, Studentenbetreuung, Praktikumsbetreuung,

Aus- und Fortbildung

MSc in Life Sciences, Chemistry for the Life Sciences, 2013, Zürcher Hochschule für Angewandte Wissenschaften

Mitglied in Netzwerken

Publikationen

Beiträge, peer-reviewed

; ; ; ; ; ; ().

An in vitro osteosarcoma 3D microtissue model for drug development

.

Journal of Biotechnology, 189 129-135. Peer reviewed.

Beiträge, nicht peer-reviewed

; ; ; ; ; ; ; ; ; ().

3D bioprinted tissue models for substance testing

: Oral presentation.

SLAS 2017, Congress, Washington DC, USA.

; ; ; ; ; ; ; ; ().

3D models for compound testing

: Oral presentation.

3D models and drug screening, Congress, Berlin, D.

; ; ; ; ; ; ; ; ().

3D tissue models - new perspectives in medicine

: Oral presentation.

CLINAM, Congress, Basel.

; ; ; ; ; ; ; ; ; ; ; ; ; ().

A novel multiwell device for drug development with bioprinted 3D human tendon and skeletal muscle tissues

.

Science Slam and Poster presentation. In: CTI Swiss Medtech Day 2016. Congress. Bern: Swiss Confederation.

; ; ; ; ; ; ; ; ; ; ; ; ; ; ().

A novel multiwell device for drug development with bioprinted 3D human tendon and skeletal muscle tissues

: Poster presentation.

Swiss Medtech Day 2016, Congress, Bern.

; ; ; ; ; ; ; ; ().

Bioprinted tissue models for substance evalution

: Oral presentation.

Basel Life Science Week 2016, Congress, Basel.

; ; ; ; ; ; ; ; ; ().

Bioprinted tissues for substance evaluation

: Oral presentation.

Biointerfaces International, Congress, Zurich.

; ; ; ; ; ; ; ().

Bioprinted tissues for substance testing

: Oral presentation.

In: 3D Cell Culture 2016: How close to 'in vivo' can we get? Models, applications & translation. Kongress. Freiburg: Dechema.

; ; ; ; ; ; ; ; ; ; ; ; ; ; ().

A novel multiwell device for drug development with bioprinted 3D human tendon and skeletal muscle tissues

: Poster presentation.

In: CTI Medtech Event. Kongress. Bern: Swiss Confederation.

; ; ; ; ; ; ; ; ().

Bioprinted muscle/tendon for drug assessment

: Poster presentation.

NTN Innovationday, Congress, Zug.

; ; ; ; ; ().

Bioprinted sof tissue models for compound testing

: Oral presentation.

Biofabrication , Congress, Utrecht, NL.

; ; ; ; ; ; ; ; ().

Soft tissue bioprinting in tissue engineering for drug development

: Oral presentation.

Oltenmeeting, biotechnet, Congress, Olten.

; ; ; ; ; ; ; ; ; ; ; ; ; ; ().

A novel multiwell device for drug development with bioprinted 3D human tendon and skeletal muscle tissues

: Poster presentation.

In: CTI Medtech Event 2014. Kongress. Bern: Swiss Confederation.

; ; ; ; ; ; ().

Human 3D osteosarcoma models for drug testing

.

Oral presentation, 3D cell culture symposium, Dechema. Freiburg (D).